Tricia Sterling

Tricia Sterling has a diverse and extensive work experience spanning over several years. Tricia began their career as a National Account Manager and Senior Territory Manager at Ferndale Laboratories in 1997. Tricia then worked as a Senior Professional Sales Representative at Fujisawa from 1999 to 2002. After that, they joined Biogen Idec as an Area Business Manager for two years. In 2004, they became a Consultant/Owner at HALTAN Group and worked there until 2009. Tricia then served as the National Service Manager at MedLearn for a brief period in 2009. Tricia subsequently worked at Shire HGT as an Associate Patient Access Director from 2010 to 2014. From 2014 to 2018, they held the position of Executive Director of Patient Care at Retrophin. Following that, they worked as a Senior Director of Patient Support Services at Amicus Therapeutics from 2018 to 2020. Tricia's next role was as the Vice President of Patient Affairs at Aeglea BioTherapeutics from 2020 to 2023. Currently, they hold the position of Executive Director of Patient Support Services at Amicus Therapeutics, starting in 2023.

Tricia Sterling completed their education at the University of St. Thomas. Tricia obtained a Bachelor's degree in Business Administration and Management from 1991 to 1993, followed by a Master of Business Administration (MBA) from 1995 to 1997.